CCEP - Coca-Cola Europacific Partners PLC
NASDAQ
->
Consumer Defensive
->
Beverages—Non-Alcoholic
Uxbridge,
United Kingdom
Type: Equity
CCEP price evolution
CCEP
| (in millions $) | 28 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $3137 | $2728 | $3068 | $2690 |
| Inventory | $1914 | $1356 | $1714 | $1380 |
| Total current assets | $7518 | $6605 | $7458 | $6543 |
| Long term investments | ||||
| Property, plant & equipment | $6458 | $5344 | $5077 | $5201 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $32101 | $29254 | $29795 | $29313 |
| Current liabilities | ||||
| Accounts payable | $5856 | $5234 | $5476 | $5052 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $8878 | $7278 | $8766 | $7313 |
| Long term debt | $10131 | $10096 | $9332 | $10571 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $23575 | $21278 | $22035 | $21866 |
| Shareholders' equity | ||||
| Retained earnings | $8234 | $7695 | $7490 | $7208 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $465 | $491 | $708 | $1739.72 |
| Short term investments | ||||
| Net receivables | $2728 | $2690 | $2494 | $1815.12 |
| Inventory | $1356 | $1380 | $1157 | $777.91 |
| Total current assets | $6605 | $6543 | $5760 | $4656.02 |
| Long term investments | ||||
| Property, plant & equipment | $5344 | $5201 | $5248 | $4409.28 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $17318.41 | |||
| Total investments | ||||
| Total assets | $29254 | $29313 | $29090 | $21974.43 |
| Current liabilities | ||||
| Accounts payable | $2306 | $2191 | $1691 | $3352.65 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $7278 | $7313 | $6093 | $4729.12 |
| Long term debt | $10096 | $10571 | $11790 | $7290.16 |
| Total noncurrent liabilities | $10362.95 | |||
| Total debt | ||||
| Total liabilities | $21278 | $21866 | $22057 | $15092.07 |
| Shareholders' equity | ||||
| Retained earnings | $8441 | $7635 | $6969 | $6942.9 |
| Other shareholder equity | -$746 | -$427 | -$161 | -$285.58 |
| Total shareholder equity | ||||
| (in millions $) | 28 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $9828 | $9325 | $8977 | $9040 |
| Cost of revenue | ||||
| Gross Profit | $3496 | $3450 | $3288 | $3251 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $2354 | $2335 | $2153 | $2113 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $234 | $287 | $247 | $213 |
| Interest expense | -$87 | -$57 | -$63 | -$51 |
| Net income | ||||
| Net income | $797 | $815 | $854 | $841 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $18302 | $17320 | $13763 | $12115.23 |
| Cost of revenue | ||||
| Gross Profit | $6806 | $6284 | $5144 | $4266.49 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $4471 | $4104 | $3568 | $3338.54 |
| Operating income | $928.69 | |||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $534 | $436 | $394 | $225.03 |
| Interest expense | -$131 | -$229 | -$200 | $164.49 |
| Net income | ||||
| Net income | $1669 | $1508 | $982 | $568.87 |
| Income (for common shares) | ||||
| (in millions $) | 28 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$1622 | -$937 | -$861 | -$645 |
| Financing activities | ||||
| Dividends paid | -$343 | -$841 | -$308 | -$763 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $332 | -$1822 | -$893 | -$2276 |
| Effect of exchange rate | $25 | -$15 | -$16 | -$31 |
| Change in cash and equivalents | -$143 | $32 | -$463 | -$20 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Net income | $793.9 | |||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $1702.03 | |||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$937 | -$645 | -$5605 | -$422.65 |
| Financing activities | ||||
| Dividends paid | -$841 | -$763 | -$638 | -$440.93 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$1822 | -$2276 | $3289 | $114.23 |
| Effect of exchange rate | -$15 | -$31 | $83 | -$14.85 |
| Change in cash and equivalents | $32 | -$20 | -$116 | $1378.76 |
News
Fundamentals
| Market cap | $33.93B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 460.37M |
| Revenue | $37.17B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $3.31B |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | 10.26 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.91 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $7.18 |
|---|---|
| ROA | 10.98% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.85 |
| Quick ratio | 0.63 |